Today ANTH ranks # as BUY CANDIDATE.
Today ANTH ranks # as BUY CANDIDATE.

ANTH stock Anthera Pharmaceuticals

ANTH stock
Anthera Pharmaceuticals

February 21, 2019
Change 11.63%
Chart period: 2018-11-23 - 2019-02-21
VOLUME
Buy
TREND
Buy

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

Will ANTH stock price go up or down on Fri, 22 Feb 2019?

Anthera Pharmaceuticals Forecast and Stock Analysis

Technical ANTH stock analysis for February 21, 2019.

Buy candidate since 2019-02-21
Shorts 2.04% ( 2018-06-15 )
Cash 17.2 mill
Loans n/a
Beta 2.73
ROA -138.08

Anthera Pharmaceuticals gained 11.63% in the last trading day, rising from $0.09 to $0.10 The price has been going up and down for this period, and there has been a 14.9% gain for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 67 127 more shares were traded than the day before. In total, 97 492 shares bought and sold for approximately $9 359.23.

Close price at the end of the last trading day (Thursday, 21st Feb 2019) of the ANTH stock was $0.10. This is 11.63% more than the trading day before Wednesday, 20th Feb 2019.

During day the stock fluctuated 12.94% from a day low at $0.09 to a day high of $0.10.

30 day high of the ANTH stock price was $0.10 and low was $0.05.
90 day high was $0.10 and low was $0.02.
52 week high for the Anthera Pharmaceuticals - $2.97 and low - $0.01.

Trend

Anthera Pharmaceuticals lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 151.58% during the next 3 months and, with 90% probability hold a price between $0.16 and $0.27 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Anthera Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $0.09 and $0.07. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday February 20, 2019, which indicates further gains until a new top pivot has been found. Anthera Pharmaceuticals has rising volume and follows the last lift in the price. This considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 70 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $0.09 and $0.08.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Anthera Pharmaceuticals finds support just below today's level at $0.09. If this is broken, then the next support from accumulated volume will be at $0.08 and $0.08.

Support: $0.09 Price: $0.10 Resistance: $0.10

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.01 between high and low, or 12.94%. For the last week, the stock has had a daily average volatility of 19.08%.

Our recommended stoploss: $0.09 (-5.43%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation: Strong Buy Candidate

Anthera Pharmaceuticals holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Strong Buy Candidate.

Today ANTH ranks # as BUY CANDIDATE.
Today ANTH ranks # as BUY CANDIDATE.